Related Experiment Video

Updated: Aug 13, 2026

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

Effect of clonixin and aspirin on platelet aggregation in human volunteers

Y S Arkel, J J Schrogie, R Williams

    Journal of Clinical Pharmacology
    |January 1, 1976
    PubMed

    Insights

    Clonixin and aspirin both affect platelet function, but clonixin shows a weaker effect than aspirin. This suggests clonixin may pose a lower risk of bleeding complications compared to aspirin.

    Area of Science:

    • Pharmacology
    • Hematology
    • Clinical Medicine

    Background:

    • Platelet aggregation is crucial for hemostasis.
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) can affect platelet function.
    • Understanding drug-specific effects on platelets is important for patient safety.

    Purpose of the Study:

    • To compare the effects of clonixin and aspirin on platelet function in healthy volunteers.
    • To evaluate the potential for hemorrhagic complications with clonixin versus aspirin.

    Main Methods:

    • Healthy volunteers were administered clonixin and aspirin.
    • Secondary platelet aggregation was measured.
    • Bleeding time was assessed.

    Main Results:

    • Both clonixin and aspirin inhibited secondary platelet aggregation.
    • Both drugs prolonged bleeding time.
    • Aspirin demonstrated a significantly greater inhibitory effect on platelet aggregation and a more pronounced prolongation of bleeding time compared to clonixin.

    Conclusions:

    • Clonixin has a less potent effect on platelet function compared to aspirin.
    • The risk of hemorrhagic complications is likely lower with clonixin than with aspirin.

    More Related Videos

    Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor06:32

    Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

    Published on: May 2, 2025

    Microfluidics in Assessing Platelet Function06:47

    Microfluidics in Assessing Platelet Function

    Published on: November 8, 2024

    Related Concept Videos

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
    Formation of the Platelet Plug01:22

    Formation of the Platelet Plug

    The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
    As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
    Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

    Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

    Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
    The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
    Drug toxicity: Drug–Drug Interaction01:30

    Drug toxicity: Drug–Drug Interaction

    Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...